Follow-up of Children With Severe Asthma at Adult Age
S2AEA
2 other identifiers
observational
60
1 country
1
Brief Summary
Most of clinical cohorts focused on the course of asthma over time and on the different phenotypes of asthma have investigated children and adults separately. The passage from childhood to adulthood is scarcely explored. In this context, we decided to explore the course of asthma severity from teenage to adulthood in children with severe asthma. The secondary objectives are to assess the quality of life and socioeconomic status in adulthood. This study will be both retrospective (data collected during childhood) and prospective (data collected during adulthood), multicentric and observational
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2021
CompletedFirst Submitted
Initial submission to the registry
August 27, 2021
CompletedFirst Posted
Study publicly available on registry
September 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2022
CompletedSeptember 2, 2021
August 1, 2021
1 year
August 27, 2021
August 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
severity and control of asthma in adulthood according to the GINA criteria
12 months
Interventions
follow-up of children with severe asthma in adulthood
Eligibility Criteria
Clinical cohort of adults patients with severe asthma in childhood
You may qualify if:
- to be aged at least 18 years old in 2021
- Have had an evaluation for severe asthma during childhood at Trousseau Hospital or Robert Debré Hospital
You may not qualify if:
- Patient without severe asthma at the time of the assessment in childhood
- Patient with an associated respiratory disease other than asthma (bronchopulmonary dysplasia, cystic fibrosis, primary ciliary dyskinesia) whose diagnosis has been invalidated or confirmed during the initial assessment
- Patient opposition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Robert Debre Hospital
Paris, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Flore AMAT, MD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2021
First Posted
September 2, 2021
Study Start
July 12, 2021
Primary Completion
July 12, 2022
Study Completion
July 12, 2022
Last Updated
September 2, 2021
Record last verified: 2021-08